IP Library Granted Patent US 11,672,553
Granted Patent B2
US 11,672,553 · App. 16/803,971 · Granted Jun 13, 2023

Method and apparatus for treatment of intracranial hemorrhages

Inventors: Robert L. Wilcox (Bothell, WA); Ronald L. Haas (Kirkland, WA)
Assignee: EKOS Corporation
A61B17/2202A61M25/00A61M25/003A61B18/24A61B2017/00084A61B2017/00561A61B2017/12004A61B2090/064A61B2090/306A61B2090/309A61B2217/005A61B2217/007A61M1/85A61M25/007A61M25/0032A61M2025/0002A61M2205/058
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,672,553
App. No.
16/803,971
Granted
Jun 13, 2023
Kind
B2
Abstract

An ultrasound catheter with fluid delivery lumens, fluid evacuation lumens and a light source is used for the treatment of intracerebral hemorrhages. After the catheter is inserted into a blood clot in the brain, a lytic drug can be delivered to the blood clot via the fluid delivery lumens while applying ultrasonic energy to the treatment site. As the blood clot is dissolved, the liquefied blood clot can be removed by evacuation through the fluid evacuation lumens.

Claims (38)

1. A method for treating a blood clot resulting from an intracranial hemorrhage in a brain of a patient, the method comprising:

advancing a tubular body through a patient's skull and into the blood clot in the brain, the tubular body including a central lumen and a fluid delivery lumen and including a distal portion configured for advancement into a patient's brain;

advancing an inner core comprising an ultrasound radiating element into the central lumen of the tubular body;

delivering a therapeutic compound through the fluid delivery lumen of the tubular body and to the blood clot positioned outside the tubular body;

transmitting ultrasound energy with the inner core to the blood clot; and

evacuating clot material from the brain through the tubular body,

wherein the tubular body further includes an evacuation lumen separate from the central lumen, and evacuating clot material occurs through the evacuation lumen.

2. The method of claim 1 , further including monitoring intracranial pressure using a pressure sensor.

3. The method of claim 2 , wherein the pressure sensor is disposed on the tubular member.

4. The method of claim 3 , wherein the pressure sensor is exposed to fluid surrounding the tubular member, and can directly measure intracranial pressure.

5. The method of claim 3 , wherein the pressure sensor is disposed in the fluid delivery lumen.

6. The method of claim 2 , wherein the tubular body further includes an evacuation lumen, and the pressure sensor includes a first pressure sensor in the fluid delivery lumen, and a second pressure sensor in the fluid evacuation lumen.

7. The method of claim 6 , further including measuring intracranial pressure by calculating the pressure drop across the first and second pressure sensors.

8. The method of claim 2 , wherein the pressure sensor includes a first pressure sensor in the fluid delivery lumen, and a second pressure sensor in the central lumen.

9. The method of claim 2 , wherein if the monitored intracranial pressure rises above a predetermined threshold, reducing the intracranial pressure below the threshold by increasing the evacuating, reducing the delivering, or both.

10. The method of claim 1 , wherein evacuating of clot material occurs through the central lumen.

11. The method of claim 1 , wherein advancing the tubular body through the patient's skull includes inserting a device configured to provide additional stiffness to the tubular body within the central lumen, and then removing the device from the central lumen after the tubular member is advanced into the patient's skull.

12. The method of claim 1 , comprising transmitting ultrasound energy at a frequency between about 20 kHz and about 20 MHz.

13. The method of claim 1 , further including maintaining an intracranial pressure below a threshold pressure while delivering the therapeutic compound.

14. The method of claim 1 , wherein the therapeutic compound includes a thrombolytic compound.

15. The method of claim 14 , wherein the therapeutic compound includes one or more of a neuroprotective agent, an anti-apoptotic agent, and a neurotoxin scavenging agent.

16. The method of claim 1 , wherein the ultrasound catheter has multiple ultrasound elements configured for use in the brain.

17. The method of claim 1 , wherein the light source is configured to emit a wavelength and amplitude of light selected for its ability to penetrate clot and brain tissue.

18. A method for treating a blood clot resulting from an intracranial hemorrhage in a brain of a patient, the method comprising:

advancing a tubular body through a patient's skull and into the blood clot in the brain, the tubular body including a central lumen and a fluid delivery lumen and including a distal portion configured for advancement into a patient's brain;

advancing an inner core comprising an ultrasound radiating element into the central lumen of the tubular body;

delivering a therapeutic compound through the fluid delivery lumen of the tubular body and to the blood clot positioned outside the tubular body;

transmitting ultrasound energy with the inner core to the blood clot;

evacuating clot material from the brain through the tubular body;

further including monitoring intracranial pressure using a pressure sensor; and

wherein the tubular body further includes an evacuation lumen, and the pressure sensors is disposed in the fluid evacuation lumen.

19. A method for treating a blood clot resulting from an intracranial hemorrhage in a brain of a patient, the method comprising:

advancing a tubular body through a patient's skull and into the blood clot in the brain, the tubular body including a central lumen and a fluid delivery lumen and including a distal portion configured for advancement into a patient's brain;

advancing an inner core comprising an ultrasound radiating element into the central lumen of the tubular body;

delivering a therapeutic compound through the fluid delivery lumen of the tubular body and to the blood clot positioned outside the tubular body;

transmitting ultrasound energy with the inner core to the blood clot;

evacuating clot material from the brain through the tubular body; and

further including activating a light source located on the tubular body or inner core.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2024
From: WILCOX, ROBERT L.; HAAS, RONALD L.
To: EKOS CORPORATION
Reel/Frame 067042/0207 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2024
From: EKOS LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 067042/0823 →
CHANGE OF NAME Recorded Apr 9, 2024
From: EKOS CORPORATION
To: EKOS LLC
Reel/Frame 067043/0077 →